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Abstract 
Iron is the most physiologically abundant transition metal with numerous applications to 
bodily systems and disease states. Too little iron will affect oxygen metabolism, a critical 
function of free iron, while excess iron has been associated with diseases including hepatitis, 
hemochromatosis, and neurological degeneration. The medical importance of iron homeostasis 
warrants research into developing accurate aqueous chemosensors. Sensors created with 
BODIPY fluorophores have been studied heavily in recent years for this purpose. Many 
published studies of these sensors identify iron binding to the probe as the source of the 
fluorescent signal. The purpose of this project was to synthesize and characterize two BODIPY 
iron sensors to demonstrate Fe3+ binding is not necessary to induce a fluorescence response. Fe3+ 
precipitates in water to produce iron (III) hydroxide, indicating that the fluorescence seen in 
published literature may not be caused by iron binding to the receptor of BODIPY. The 
compounds created in this MQP do not have a strong binding affinity, therefore it was 
hypothesized that if the molecule still fluoresces, this is due to other causes and can be used 
comparatively as a control when studying BODIPY based molecules that have strong Fe3+ 
recognition units. 
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1. Introduction 
Iron is the most physiologically abundant transition metal and has roles in numerous 
cellular functions.1 Humans as well as other mammals and even bacteria require iron for 
biological processes including oxygen metabolism, electron transfer, transcription and 
reproduction.2-5 Due to iron’s abundance and versatility in the body, it also plays a role in many 
disease states.  Levels of iron are normally maintained by homeostasis, however, iron 
concentration can fluctuate in the body resulting in illness. Too little iron in the body can weaken 
the immune system and cause blood clotting disorders, while excess iron in the body has been 
associated with the development of cancer, hepatitis and hemochromatosis.6, 7 Additionally, 
much effort has been recently devoted to the study of iron’s potential roles in neurodegenerative 
diseases such as Parkinson’s and Alzheimer’s.8-11  
 The clinical significance of iron homeostasis warrants research into developing accurate 
chemosensors which can detect Fe3+ under aqueous conditions. A chemosensor is a molecule 
which contains a receptor site that binds to the target analyte, in this case Fe3+, resulting in a 
response from the signaling unit of the molecule. One molecule which is particularly useful for 
this application is BODIPY, a fluorophore which has been researched extensively in recent 
years.12, 13 Some published research cites studies of these sensors in methanol which then 
extrapolate the results to water-based systems.  
The Burdette research group has synthesized several BODIPY-based sensors, and this 
MQP is a continuation of that research.1, 14 More specifically, this project hypothesized that these 
BODIPY-based sensors for iron may not be working as reported in aqueous solution due to the 
fact that Fe3+ will precipitate in water to form iron (III) hydroxide. To study this, two BODIPY-
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based sensors with a weak binding affinity for iron were synthesized. Both hydroxy and methoxy 
BODIPY derivatives were synthesized and characterized by 1H NMR, 13C NMR, LC-MS, and 
FT-IR. In future research, these sensors will be studied using UV-vis and fluorescence studies 
and compared to the published fluorescence data of iron-specific BODIPY sensors. 
2. Background 
It is important to understand the clinical significance of iron homeostasis, its biological 
abundance and why we need to research how to accurately detect levels of iron in solution. 
BODIPY-based iron sensors will be introduced as a way to detect iron in organic solutions, and 
potential downfalls of these sensors in aqueous solution will be discussed. 
2.1 Clinical Significance of Iron Metal Ions 
 Iron is the most physiologically abundant transition metal and has roles in numerous 
biological processes including oxygen metabolism, electron transfer, transcription and 
reproduction.1-5 Research into iron homeostasis has uncovered that iron imbalances in the body 
play roles in many different diseases including anemia, blood clotting disorders, hepatitis, 
hemochromatosis and some cancers.6,7 Additionally, recent research has suggested that there 
may be a link between iron and neurodegenerative diseases such as Parkinson’s and Alzheimer’s 
[8-11]. It is thought that ferrous iron reacts with hydrogen peroxide via the Fenton Reaction to 
form hydroxide and also hydroxyl free radicals (OH).15 These hydroxyl free radicals are very 
reactive and suspected to play a role in the development and progression of neurodegeneration.16-
18 Due to iron’s abundance and complex roles in biological processes and disease states, it 
warrants research into developing accurate chemosensors which can function in aqueous 
solution. 
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2.2 Chemosensors 
 A chemosensor is a molecule which contains a signaling unit, spacer, and receptor site. 
The target being sensed, in this case Fe3+, is known as the analyte. When the analyte binds to the 
specific receptor site, the signaling unit responds. In the case of this MQP, the signaling unit 
responds by fluorescing.  
 
Figure 1: Chemosensor Mechanics. A receptor site binds to the desired analyte resulting in a 
response from the signaling unit. This response results in the molecule “sensing” the presence of 
the analyte. 
2.2 BODIPY Fluorophores 
 BODIPY, also known as boron dipyrromethene, is an organic dye which possesses many 
unique photophysical properties. Due to this, it is a great fluorophore to be used as the signaling 
unit in a chemosensor. When iron binds to the receptor unit of the molecule, it allows for 
electron flow through the iron which, in turn, results in the visible BODIPY fluorescence. 
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Figure 2: BODIPY-based Chemosensor Example. The sensor without Fe3+ present induces 
minimal fluorescence response, however, upon addition of the analyte, the sensor binds to iron 
and the signaling unit fluoresces.19 
2.3 Existing Research 
 A published study of BODIPY-based iron sensors was used to make hypotheses which 
partially formed the basis of this MQP. The study in question used a BODIPY sensor which was 
responsive to iron to demonstrate the ability for the molecule to act as a turn-on fluorescence 
probe.19 
 
Figure 3: Iron-specific BODIPY sensor. This molecule has a strong binding affinity for iron 
when compared to the molecules synthesized in this MQP, therefore it can be used 
comparatively to assess differences in fluorescence.19 
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This sensor was then used in cells to show the effect on fluorescence in cells with just sensor and 
with sensor and iron present.19 
 
Figure 4: Cellular Imaging of BODIPY Sensor Florescence Function. The top row represents 
cells treated with sensor and iron, while the bottom row represents cells treated with just sensor. 
The difference from column 1 to column 2 is 1hr incubation time.19 
This figure provoked further inquiry into understanding how the iron probes were analyzed in 
cells. The top row of cells visually appeared to be of higher confluency, while the bottom row of 
cells appeared visually blurry. The fluorescence displayed in the bottom row of cells, meant to 
act as a control of just sensor, indicates that iron binding may potentially not be required for 
these BODIPY-based sensors to fluoresce. Fluorescence may be caused by something else. 
Determining the true cause of BODIPY-sensor florescence is the long-term objective of this 
project. 
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3. Methodology 
3.1 General Synthetic Procedures 
All materials were obtained in the highest purity available from Fisher, Acros Organic and Alfa 
Aesar and used without further purification. Solvents were purged with argon and dried using a 
Seca Solvent Purification System. 1H and 13C NMR were recorded using a 500 MHz Bruker-
Biospin NMR instrument, and chemical shifts are reported in ppm on the δ scale relative to 
tetramethylsilane (TMS). FT-IR spectra were recorded using Bruker Optics Vertex 70 with MIR 
source as neat crystalline powdered samples and Spectrum 100 Version 10.4.2 (PerkinElmer) 
fitted with diamond ATR as oils. Melting-point information was obtained using Hydrothermal 
Mel-Temp instrument. Full syntheses are shown in Scheme 1 and Scheme 2. 
 
Scheme 1: Hydroxy Compound Synthesis 
3.2 Hydroxy Aldehyde 
 4-[bis(2-hydroxyethyl)amino]benzaldehyde (2) N-phenyldiethanolamine (2.0 g, 11.0 mmol) 
was combined with phosphorus oxychloride (8.43 g, 55.0 mmol) in DMF (20 mL). After 24 h in 
a 60 ° C oil bath, the reaction mixture was applied over ice and neutralized to pH 7 with 
saturated NaHCO3. The product was extracted using saturated NaCl solution and ethyl acetate (3 
(1) (2) (3) 
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× 50 mL). The combined extracts were dried over NaSO4. Solvent removal under reduced 
pressure yielded yellow oil. The resultant oil was purified using column chromatography with 
1:1 hexanes: ether as the eluent and yielded a white solid (1.17 g, 50.4 % yield); mp =80-82 ° C. 
1H NMR (500 MHz, CDCl3) δ 9.79 (s, 1 H), 7.79 (d, J = 9.0 Hz, 2 H), 6.76 (d, J = 9.0 Hz, 2 H), 
3.86 (t, J = 7.0 Hz, 4 H), 3.70 (t, J = 7.0 Hz, 4 H). 13C NMR (500 MHz, CDCl3) δ 190.4, 151.2, 
132.5, 111.5, 53.5, 40.2. FT-IR (neat, cm-1) 2963.8, 2822.2, 2747.0, 2324.5, 2163.9, 1665.8, 
1588.9, 1559.9, 1521.2, 1461.1, 1433.0, 1403.0, 1360.9, 1313.0, 1284.2, 1254.3, 1240.9, 1215.6, 
1194.1, 1163.2, 1124.3, 1032.1, 1000.8, 961.5, 837.7, 817.1, 806.1, 784.2, 747.3, 712.9, 637.2. 
HRMS (+ESI) calculated (C11H15NO3) for 209.2 and observed 248.0 [M
+K+].  
3.3 Hydroxy Bodipy  
[[2,2-[[4-[(3,5-dimethyl-1H-pyrrol-2-yl- κN)(3,5-dimethyl-2H-pyrrol-2-ylidene-
κN)methyl]phenyl]imino]bis[ethanolato]](1-)] difluoro-, (T-4)-boron (3) 2, 4-dimethylpyrrole 
(0.43 g, 48 mmol) was combined with compound 2 (0.43 g, 21.6 mmol) in 30 mL DCM. After 
initial mixing, 4 drops trifluoroacetic acid (TFA) was added and left to stir under nitrogen for 24 
h at room temperature. DDQ (0.48 g, 2.13 mmol) was then mixed with DCM (20 mL) and added 
1 mL/min to the reaction mixture. The reaction was stirred at room temperature for 24 h and then 
triethyl amine (8 mL) was added and left to stir at room temperature. After 30 minutes, 
borontrifluoride ethelate (6.6 mL) was added and the reaction stirred for 24 h at room 
temperature. The product was extracted using saturated NaCl solution and DCM (3 × 75 mL). 
The combined extracts were dried over NaSO4. Solvent removal under reduced pressure yielded 
black oil. The resultant oil was purified using column chromatography with 1:1 hexanes: ether as 
the eluent and yielded a red solid (536 mg, 27.6 % yield); mp = 148-150 ° C. 1H NMR (500 
MHz, CDCl3) δ 7.12 (d, J = 8.8 Hz, 2 H), 5.98 (s, 2 H), 3.80 (t, J = 7.1 Hz, 4 H), 3.69 (t, J = 6.9 
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Hz, 4 H), 2.55 (s, 6 H), 1.47(s, 7 H). 13C NMR (500 MHz, CDCl3) δ 155.3, 146.9, 143.3, 142.4, 
132.3, 129.7, 124.1, 121.3, 112.4, 53.7, 40.5, 29.9, 14.9, 14.8. FT-IR (neat, cm-1) 2963.1, 
2927.3, 2907.7, 2870.6, 2359.7, 2324.7, 1981.2, 1726.4, 1606.3, 1539.0, 1506.4, 1470.3, 1444.4, 
1406.3, 1354.2, 1305.3, 1265.3, 1237.7, 1187.9, 1156.6, 1124.3, 1085.1, 1049.8, 986.8, 969.7, 
919.3, 874.4, 840.8, 813.9, 762.2, 705.0, 657.4, 607.3. HRMS (+ESI) calculated (C13H19NO3) for 
237.2 and observed 238.1 [H+].   
 
 
 
 
 
 
Scheme 2: Methoxy Compound Synthesis 
3.4 Methoxy Aldehyde  
4-[bis(2-methoxyethyl)amino]benzaldehyde (5) N-phenyldiethanolamine (2.0 g, 11 mmol) was 
added to THF (30 mL), stirring under nitrogen. Sodium hydride (2.2 g, 91 mmol) was added to 
(1) (4) 
(5) 
(6) 
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the reaction mixture slowly and then refluxed at room temperature for 30 minutes, 40 ° C for 30 
minutes and then brought back to room temperature. Methyl iodide (3.43 mL) was added to the 
reaction mixture slowly and allowed to stir overnight at room temperature. The product 
(compound 4) was extracted using saturated NaCl solution and DCM (3 × 50 mL). The 
combined extracts were dried over NaSO4. Solvent removal under reduced pressure yielded 
yellow oil. The resultant oil was purified using silica column chromatography with 1:1 hexanes: 
ether as the eluent and yielded a clear oil. This compound was then used as a starting material for 
the aldehyde. Compound 4 (0.15 g, 0.72 mmol) was added to DMF (4 mL). Phosphorus 
oxychloride (0.55 g, 3.59 mmol) was added to the reaction mixture slowly. After 24 h in a 60 ° C 
oil bath, the reaction mixture was applied over ice and neutralized to pH 7 with saturated 
NaHCO3. The product was extracted using saturated NaCl solution and ethyl acetate (3 × 50 mL). 
The combined extracts were dried over NaSO4. Solvent removal under reduced pressure yielded 
brown oil. The resultant oil was purified using column chromatography with 1:1 hexanes: ether 
as the eluent and yielded a yellow oil (0.39 g, 24.4 % yield); 1H NMR (500 MHz, CDCl3) δ 9.73 
(s, 1 H), 7.71 (d, J = 9.3 Hz, 2 H), 6.75 (d, J = 9.4 Hz, 2 H), 3.66 (t, J = 5.9 Hz, 4 H), 3.58 (t, J = 
5.8 Hz, 4 H), 3.35 (s, 6 H). 13C NMR (500 MHz, CDCl3) δ 190.2, 152.8, 132.3, 125.5, 111.2, 
70.0, 59.2, 51.2. FT-IR (neat, cm-1) 2924.9, 2879.0, 2812.6, 2733.9, 2152.8, 2028.4, 1666.8, 
1590.2, 1555.8, 1522.7, 1452.4, 1434.1, 1399.7, 1356.7, 1314.3, 1279.1, 1237.9, 1197.3, 1165.0, 
1108.0, 1009.9, 1000.1, 959.7, 908.9, 813.8, 729.8, 710.4. HRMS (+ESI) calculated 
(C11H15NO3) for 209.2 and observed 248.0 [M
+K+].  
3.5 Methoxy Bodipy 
[[2,2-[[4-[(3,5-dimethyl-1H-pyrrol-2-yl- κN)(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)methyl] 
phenyl]imino]bis[methoxyethanolato]](1-)] difluoro-, (T-4)-boron (6) 2,4-dimethylpyrrole 
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(0.34 g, 3.58 mmol) was added to compound 4 (0.39 g, 1.63 mmol) in DCM (25 mL). After 
initial mixing, 3 drops trifluoroacetic acid was added and left to stir under nitrogen for 24 h at 
room temperature. DDQ (0.38 g, 1.68 mmol) was then mixed with DCM (20 mL) and added 1 
mL/min to the reaction mixture. The reaction was stirred at room temperature for 24 h and then 
triethyl amine (6 mL) was added and left to stir at room temperature. After 30 minutes, 
borontrifluoride ethelate (2.98 g, 21 mmol) was added and the reaction stirred for 24 h at room 
temperature. The product was extracted using saturated NaCl solution and DCM (3 × 75 mL). 
The combined extracts were dried over NaSO4. Solvent removal under reduced pressure yielded 
black oil. The resultant oil was purified using silica column chromatography with 1:1 hexanes: 
ether as the eluent and yielded a red solid (trace yield); mp = 110-114 ° C. 1H NMR (500 MHz, 
CDCl3) δ 7.07 (d, J = 8.9 Hz, 2 H), 8.86 (d, J = 8.9 Hz, 2 H), 6.07 (s, 2 H), 3.56 (m, 8 H), 3.31 (s, 
6 H). 13C NMR (500 MHz, CDCl3) δ 154.9, 148.7, 143.4, 132.4, 129.2, 122.4, 121.1, 112.4, 70.2, 
59.3, 51.2, 29.9, 14.9. FT-IR (neat, cm-1) 3098.7, 2957.7, 2923.0, 2884.1, 2824.9, 2738.0, 
2339.4, 1727.5, 1668.4, 1606.8, 1540.3, 1525.8, 1499.8, 1468.4, 1396.0, 1359.9, 1305.6, 1295.1, 
1265.5, 1232.7, 1188.2, 1156.9, 1106.4, 1061.8, 1009.3, 970.1, 902.2, 813.7, 761.8, 703.8, 647.8. 
HRMS (+ESI) calculated (BC25F2H32N3O2) for 455.3 and observed 455.3 and 456.2 [H
+].  
Conclusions & Future Research 
 This research resulted in the synthesis and characterization of two BODIPY sensors 
which do not have a strong binding affinity for iron. To further this research, these sensors 
should be studied using UV-vis, titration experiments with iron, and fluorescence studies. 
Additionally, these sensors should be compared side-by-side with another published BODIPY 
sensor which is known to bind to iron in both organic solvent and aqueous solvent to 
demonstrate differences and similarities in fluorescence response. Finally, these sensors should 
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be used in cells and cellular images should be taken which show florescence under varying 
sensor and Fe3+ conditions. If the sensors created in this MQP, which should not bind iron, show 
similar fluorescence responses when compared to the BODIPY sensors which should bind iron, 
that may provide evidence that iron binding is not necessary to induce a fluorescence response. 
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Supplementary Figure 6: Hydroxy BODIPY 13C NMR 
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Supplementary Figure 7: Hydroxy BODIPY LC-MS 
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Supplementary Figure 8: Hydroxy BODIPY Transmittance 
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Supplementary Figure 10: Methoxy Aldehyde 1H NMR 
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Supplementary Figure 11: Methoxy Aldehyde 13C NMR 
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Supplementary Figure 12: Methoxy Aldehyde LC-MS 
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Supplementary Figure 13: Methoxy Aldehyde Transmittance 
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